Search

everythinglearnresearchcommunity

for

Search:↓

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Single-dose parenteral iron is safe and effective for children with inflammatory bowel disease and iron-deficiency anemia.

CGF and i-PRF are more effective and safer than PRP for treating female pattern hair loss.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Entospletinib effectively prevents eye and skin GVHD in mice.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Baricitinib helps treat severe hair loss in people over 65.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Baricitinib is effective and safe for treating severe alopecia areata.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

CD101 is highly effective in treating dermatophytosis in guinea pigs.